| Dr Tatyana Pankratova, MD | |
|
2128 Blakeslee Boulevard Dr E, Lehighton, PA 18235-9619 | |
| (610) 402-5369 | |
| Not Available |
| Full Name | Dr Tatyana Pankratova |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 32 Years |
| Location | 2128 Blakeslee Boulevard Dr E, Lehighton, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013216324 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Temple University Hospital | Philadelphia, PA | Hospital |
| Saint Anne's Hospital | Fall river, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Temple Physicians Inc | 2062317233 | 127 |
| Prima Care Pc | 2567356017 | 186 |
News Archive
In this pair of articles, news outlets report on how technology is playing a role in health care.
Genome editing using CRISPR/Cas9 "gene scissors" is a powerful tool for biological discovery and for identifying novel drug targets.
Cochlear implantation is a safe and effective treatment option for patients with far advanced otosclerosis who have not benefitted from stapedectomy, report US researchers.
An innovative new app could help enhance home and hospital environments for people with dementia - improving patient outcomes and reducing the strain on health services, according to University of Stirling academics.
A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. The CTRC has started patient enrollment in a US Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with carboplatin and paclitaxel in patients with SCC lung cancer.
› Verified 5 days ago
| Entity Name | Regional Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174520654 PECOS PAC ID: 4880593722 Enrollment ID: O20040108000694 |
News Archive
In this pair of articles, news outlets report on how technology is playing a role in health care.
Genome editing using CRISPR/Cas9 "gene scissors" is a powerful tool for biological discovery and for identifying novel drug targets.
Cochlear implantation is a safe and effective treatment option for patients with far advanced otosclerosis who have not benefitted from stapedectomy, report US researchers.
An innovative new app could help enhance home and hospital environments for people with dementia - improving patient outcomes and reducing the strain on health services, according to University of Stirling academics.
A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. The CTRC has started patient enrollment in a US Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with carboplatin and paclitaxel in patients with SCC lung cancer.
› Verified 5 days ago
| Entity Name | The Milton S Hershey Medical Center Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710951744 PECOS PAC ID: 3870405483 Enrollment ID: O20040225000741 |
News Archive
In this pair of articles, news outlets report on how technology is playing a role in health care.
Genome editing using CRISPR/Cas9 "gene scissors" is a powerful tool for biological discovery and for identifying novel drug targets.
Cochlear implantation is a safe and effective treatment option for patients with far advanced otosclerosis who have not benefitted from stapedectomy, report US researchers.
An innovative new app could help enhance home and hospital environments for people with dementia - improving patient outcomes and reducing the strain on health services, according to University of Stirling academics.
A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. The CTRC has started patient enrollment in a US Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with carboplatin and paclitaxel in patients with SCC lung cancer.
› Verified 5 days ago
| Entity Name | Temple Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942444088 PECOS PAC ID: 2062317233 Enrollment ID: O20040310000054 |
News Archive
In this pair of articles, news outlets report on how technology is playing a role in health care.
Genome editing using CRISPR/Cas9 "gene scissors" is a powerful tool for biological discovery and for identifying novel drug targets.
Cochlear implantation is a safe and effective treatment option for patients with far advanced otosclerosis who have not benefitted from stapedectomy, report US researchers.
An innovative new app could help enhance home and hospital environments for people with dementia - improving patient outcomes and reducing the strain on health services, according to University of Stirling academics.
A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. The CTRC has started patient enrollment in a US Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with carboplatin and paclitaxel in patients with SCC lung cancer.
› Verified 5 days ago
| Entity Name | Nazareth Physician Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285150458 PECOS PAC ID: 0941229017 Enrollment ID: O20171026001610 |
News Archive
In this pair of articles, news outlets report on how technology is playing a role in health care.
Genome editing using CRISPR/Cas9 "gene scissors" is a powerful tool for biological discovery and for identifying novel drug targets.
Cochlear implantation is a safe and effective treatment option for patients with far advanced otosclerosis who have not benefitted from stapedectomy, report US researchers.
An innovative new app could help enhance home and hospital environments for people with dementia - improving patient outcomes and reducing the strain on health services, according to University of Stirling academics.
A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. The CTRC has started patient enrollment in a US Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with carboplatin and paclitaxel in patients with SCC lung cancer.
› Verified 5 days ago
| Entity Name | Temple Faculty Practice Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881176949 PECOS PAC ID: 0345588711 Enrollment ID: O20190208002623 |
News Archive
In this pair of articles, news outlets report on how technology is playing a role in health care.
Genome editing using CRISPR/Cas9 "gene scissors" is a powerful tool for biological discovery and for identifying novel drug targets.
Cochlear implantation is a safe and effective treatment option for patients with far advanced otosclerosis who have not benefitted from stapedectomy, report US researchers.
An innovative new app could help enhance home and hospital environments for people with dementia - improving patient outcomes and reducing the strain on health services, according to University of Stirling academics.
A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. The CTRC has started patient enrollment in a US Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with carboplatin and paclitaxel in patients with SCC lung cancer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tatyana Pankratova, MD 1460 G St, Springfield, OR 97477-4112 Ph: (541) 744-8613 | Dr Tatyana Pankratova, MD 2128 Blakeslee Boulevard Dr E, Lehighton, PA 18235-9619 Ph: (610) 402-5369 |
News Archive
In this pair of articles, news outlets report on how technology is playing a role in health care.
Genome editing using CRISPR/Cas9 "gene scissors" is a powerful tool for biological discovery and for identifying novel drug targets.
Cochlear implantation is a safe and effective treatment option for patients with far advanced otosclerosis who have not benefitted from stapedectomy, report US researchers.
An innovative new app could help enhance home and hospital environments for people with dementia - improving patient outcomes and reducing the strain on health services, according to University of Stirling academics.
A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. The CTRC has started patient enrollment in a US Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with carboplatin and paclitaxel in patients with SCC lung cancer.
› Verified 5 days ago
Dr. Hasan Bayat, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 N 12th St, Lehighton, PA 18235 Phone: 610-377-7174 Fax: 610-377-4785 | |
Dr. Harry T Berger, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 281 N 12th St, Suite B, Lehighton, PA 18235 Phone: 610-377-7793 Fax: 610-377-9241 | |
Dr. Todd Richard Banning, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1241 Blakeslee Boulevard Dr E, Lehighton, PA 18235 Phone: 570-386-6900 Fax: 570-386-6901 | |
Andrew E Schwartz, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 204 State Rd, Lehighton, PA 18235 Phone: 610-379-0443 Fax: 610-379-4725 | |
Robert A Durako, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Mahoning St, Lehighton, PA 18235 Phone: 610-379-0200 Fax: 610-379-0216 | |
William M Markson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1241 Blakeslee Boulevard Dr E, Lehighton, PA 18235 Phone: 570-386-6900 Fax: 570-386-6901 |